For: | Zahid MF, Parnes A, Savani BN, Litzow MR, Hashmi SK. Therapy-related myeloid neoplasms - what have we learned so far? World J Stem Cells 2016; 8(8): 231-242 [PMID: 27621757 DOI: 10.4252/wjsc.v8.i8.231] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v8/i8/231.htm |
Number | Citing Articles |
1 |
Sang-A Kim, Junshik Hong, Woo Chan Park, Dong-Yeop Shin, Youngil Koh, Inho Kim, Dong Soon Lee, Sung-Soo Yoon, Marina Konopleva. Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype. PLOS ONE 2018; 13(12): e0209800 doi: 10.1371/journal.pone.0209800
|
2 |
Francesca Roncaglia, Pamela Mancuso, Massimo Vicentini, Antonio Vitiello, Luigi Vecchia, Stefano Luminari, Lucia Mangone, Manuel Zorzi, Carlo La Vecchia, Paolo Giorgi Rossi. New information flows for cancer registries: testing the use of laboratory data in the province of Reggio Emilia, Italy. European Journal of Cancer Prevention 2020; 29(6): 548 doi: 10.1097/CEJ.0000000000000585
|
3 |
Naomi D. Atkin, Heather M. Raimer, Zhenjia Wang, Chongzhi Zang, Yuh‐Hwa Wang. Assessing acute myeloid leukemia susceptibility in rearrangement‐driven patients by DNA breakage at topoisomerase II and CCCTC‐binding factor/cohesin binding sites. Genes, Chromosomes and Cancer 2021; 60(12): 808 doi: 10.1002/gcc.22993
|
4 |
T. F. Liubarets. TR53 AND IONIZING RADIATION: THE ROLE IN THE PATHOGENESIS AND PROGNOSIS OF THE COURSE OF ACUTE MYELOID LEUKEMIA (literature review). Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology 2024; 29: 67 doi: 10.33145/2304-8336-2024-29-67-78
|
5 |
Anne Calleja, Seongseok Yun, Chimène Moreilhon, Jean Michel Karsenti, Lauris Gastaud, Lionel Mannone, Rami Komrokji, Najla al Ali, Bérangère Dadone‐montaudie, Guillaume Robert, Patrick Auberger, Sophie Raynaud, David A. Sallman, Thomas Cluzeau. Clonal selection in therapy‐related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment. European Journal of Haematology 2020; 104(5): 488 doi: 10.1111/ejh.13390
|
6 |
Christine Beham-Schmid, Annette Schmitt-Graeff. Bone Marrow Biopsy Pathology. Essentials of Diagnostic Pathology 2020; : 27 doi: 10.1007/978-3-662-60309-3_2
|
7 |
M. Chantadisai, H. R. Kulkarni, R. P. Baum. Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(5): 1390 doi: 10.1007/s00259-020-05127-9
|
8 |
Tomáš Szotkowski, Martin Čerňan, Jaromír Hubáček, Milena Holzerová, Tomáš Papajík. Anticancer therapy - related acute myeloid leukemias. Onkologie 2017; 11(3): 115 doi: 10.36290/xon.2017.023
|
9 |
Neerav Shukla. Acute Myeloid Leukemia in Children. Pediatric Oncology 2024; : 211 doi: 10.1007/978-3-031-63366-9_12
|
10 |
Naomi Atkin, Heather Raimer, Yuh-Hwa Wang. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility. Genes 2019; 10(10): 791 doi: 10.3390/genes10100791
|
11 |
Sergio Pina-Oviedo, Haitham A. Khogeer, Guilin Tang, Roberto N. Miranda. Oncological Surgical Pathology. 2020; : 1729 doi: 10.1007/978-3-319-96681-6_17
|
12 |
Uma Borate, Brianna A. Norris, Abby Statler, Rongwei Fu, Taylor Bucy, Mikkael A. Sekeres. Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years. Blood Advances 2019; 3(18): 2738 doi: 10.1182/bloodadvances.2019000293
|